Lucknow Speciality Pharma

Osimertinib Tablets 80 mg
Osimertinib Tablets is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have certain types of abnormal epidermal growth factor (EGFR) genes To get access, please contact Patient Support Team @ +91 9760014849 / 9555306364 / 9794360370 / 9140551027, Time 9 am - 8 pm IST or send us a request on email (urgent@lucknowpharma.com) / WhatsApp for the same.
Get Access Price
WhatsApp

Osimertinib Tablets was approved for medical use in the United States in 2015. It is on the World Health Organization’s List of Essential Medicines.

Osimertinib Tablets Available Price In Lucknow Banaras Nepal

Osimertinib Tablets

  • Generic Brand Available – TAGRISSO
  • API – Osimertinib Tablets
  • Packaging – 10 Tablets
  • Strength – 80 mg

What is Osimertinib Tablets used for?

Osimertinib Tablets is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have certain types of abnormal epidermal growth factor (EGFR) genes.

Facts of Medicines

Osimertinib Tablets 80 mg

STORAGE AND HANDLING

Care should be exercised in the handling of osimertinib  tablets should not be opened or crushed. Store permitted between 20-25°C (68-77°F).

DOSAGE

Tablets: 80 mg and 40 mg

Confirm the presence of T790M mutation in tumor specimens prior to initiation of treatment with TAGRISSO. 80 mg orally once daily, with or without food.

SIDE EFFECTS

  • Most common adverse reactions (≥25%) were diarrhea, rash, dry skin, and nail toxicity.

WARNINGS AND PRECAUTIONS

  • Interstitial Lung Disease (ILD)/Pneumonitis: Occurred in 3.3% of patients. Permanently discontinue TAGRISSO in patients diagnosed with ILD/Pneumonitis.
  • Cardiomyopathy: Occurred in 1.4% of patients. Assess left ventricular ejection fraction (LVEF) before treatment and then every 3 months thereafter.
  • Embryo-Fetal Toxicity: TAGRISSO can cause fetal harm. Advise females of potential risk to the fetus and to use effective contraception during treatment with TAGRISSO and for 6 weeks after final dose. Advise males to use effective contraception for 4 months, after the last dose of TAGRISSO.

FAQs – Medicine Questions

Osimertinib Tablets 80 mg
What is osimertinib used for?
Osimertinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have certain types of abnormal epidermal growth factor (EGFR) genes
Is osimertinib a tablet?
Osimertinib comes as a tablet to take by mouth. It is usually taken with or without food once a day. The length of your treatment depends on how well this medication works for you, and the side effects that you experience. Take osimertinib at around the same time every day.
How effective is osimertinib?
Osimertinib reduced the risk for disease recurrence or death by 79% in (HR, 0.21; 95% CI, 0.16-0.28; P <. 0001). Osimertinib was associated with superior DFS rates at 1 (97% vs 69%), 2 (89% vs 53%), and 3 years (79% vs 41%).
Where can I buy Osimertinib Tablets?

You can buy Osimertinib Tablets from any authorized whole-seller after getting a prescription from a qualified doctor. It is always better to check the credential of the whole-seller/supplier/exporter before buying the product.

The buyer should check the existing law in their home country before importing the product.

What is the procedure to buy Osimertinib Tablets?

Patients can simply fill the order form or can send mail at info@lucknowpharma.com Patients can also send WhatsApp messages to +91-9555306364 We will reply ASAP with the details of the Osimertinib Tablets price as well as procurement procedure.

Note:- The order will be confirmed only after the receipt of the Valid prescription of the Clinician.

Is Tagrisso a chemotherapy?
No, Tagrisso is not a chemotherapy, but a targeted therapy. Targeted therapies work differently than traditional chemotherapy. Chemotherapy kills rapidly dividing cells, and can affect many types of cells in the body, including healthy cells.

NEWS / UPDATES

  1. Edward Chu, Cancer Chemotherapy, Lange’s Basic and Clinical Pharmacology, 14th Edition, 2018, 948-976.
  2. AstraZeneca Pharmaceuticals, Electronic Medicines Compendium (EMC) [Revised on Jan 2021] [Accessed on 30th Nov 2021], https://www.medicines.org.uk/emc/files/pil.7615.pdf
  3. AstraZeneca Pharmaceuticals, U.S. Food and Drug Administration, [Revised on Jul 2021] [Accessed on 30th Nov 2021], https://den8dhaj6zs0e.cloudfront.net/50fd68b9-106b-4550-b5d0-12b045f8b184/52503580-1192-44f7-a05e-5743159ed19b/52503580-1192-44f7-a05e-5743159ed19b_viewable_rendition__v.pdf